Clinical effectiveness of dolutegravir in the treatment of HIV/AIDS - Document - Gale Academic OneFile
![Metabolism, Excretion, and Mass Balance of the HIV-1 Integrase Inhibitor Dolutegravir in Humans | Antimicrobial Agents and Chemotherapy Metabolism, Excretion, and Mass Balance of the HIV-1 Integrase Inhibitor Dolutegravir in Humans | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/AAC.00292-13/asset/3703e98b-e5bb-4d2f-b10d-d176b3a2b90a/assets/graphic/zac9991019880006.jpeg)
Metabolism, Excretion, and Mass Balance of the HIV-1 Integrase Inhibitor Dolutegravir in Humans | Antimicrobial Agents and Chemotherapy
![Dolutegravir dosing for children with HIV weighing less than 20 kg: pharmacokinetic and safety substudies nested in the open-label, multicentre, randomised, non-inferiority ODYSSEY trial - The Lancet HIV Dolutegravir dosing for children with HIV weighing less than 20 kg: pharmacokinetic and safety substudies nested in the open-label, multicentre, randomised, non-inferiority ODYSSEY trial - The Lancet HIV](https://www.thelancet.com/cms/attachment/4dcbeea0-d1ac-4fc6-9a1d-4e40e9d1d7fa/gr2_lrg.jpg)
Dolutegravir dosing for children with HIV weighing less than 20 kg: pharmacokinetic and safety substudies nested in the open-label, multicentre, randomised, non-inferiority ODYSSEY trial - The Lancet HIV
![Dosing Considerations | See Boxed Warning for TRIUMEQ & TRIUMEQ PD (abacavir, dolutegravir, lamivudine) Dosing Considerations | See Boxed Warning for TRIUMEQ & TRIUMEQ PD (abacavir, dolutegravir, lamivudine)](https://i-cf65.gskstatic.com/content/dam/cf-viiv/triumeq-hcp/master/triumeq_pd_chart_desktop_v4.png?auto=format)
Dosing Considerations | See Boxed Warning for TRIUMEQ & TRIUMEQ PD (abacavir, dolutegravir, lamivudine)
![Dolutegravir or lower-dose efavirenz equally effective, but less resistance with dolutegravir | aidsmap Dolutegravir or lower-dose efavirenz equally effective, but less resistance with dolutegravir | aidsmap](https://www.aidsmap.com/sites/default/files/styles/aidsmap_social_default/public/2020-06/dolutegravir-or-lower-dose-efavirenz-equally-effective-but-less-resistance-with-dolutegravir.jpg.png?itok=4xxBLlNv)
Dolutegravir or lower-dose efavirenz equally effective, but less resistance with dolutegravir | aidsmap
![Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial - The Lancet HIV Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial - The Lancet HIV](https://www.thelancet.com/cms/attachment/8629ef3a-1809-4aa9-8364-a43750f744fa/gr1_lrg.gif)
Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial - The Lancet HIV
![Dolutegravir dosing for children with HIV weighing less than 20 kg: pharmacokinetic and safety substudies nested in the open-label, multicentre, randomised, non-inferiority ODYSSEY trial - The Lancet HIV Dolutegravir dosing for children with HIV weighing less than 20 kg: pharmacokinetic and safety substudies nested in the open-label, multicentre, randomised, non-inferiority ODYSSEY trial - The Lancet HIV](https://www.thelancet.com/cms/attachment/433edd2b-fff4-445f-b185-84f12030ea5b/gr1_lrg.gif)
Dolutegravir dosing for children with HIV weighing less than 20 kg: pharmacokinetic and safety substudies nested in the open-label, multicentre, randomised, non-inferiority ODYSSEY trial - The Lancet HIV
![SINGLE AND MULTIPLE DOSE DOLUTEGRAVIR PHARMACOKINETICS IN THE GENITAL TRACT AND COLORECTUM OF HIV NEGATIVE MEN AND WOMEN SINGLE AND MULTIPLE DOSE DOLUTEGRAVIR PHARMACOKINETICS IN THE GENITAL TRACT AND COLORECTUM OF HIV NEGATIVE MEN AND WOMEN](https://www.natap.org/2013/images/040413/040413-3/CROI1.gif)
SINGLE AND MULTIPLE DOSE DOLUTEGRAVIR PHARMACOKINETICS IN THE GENITAL TRACT AND COLORECTUM OF HIV NEGATIVE MEN AND WOMEN
![Dolutegravir mean plasma concentration versus time profiles by weight... | Download Scientific Diagram Dolutegravir mean plasma concentration versus time profiles by weight... | Download Scientific Diagram](https://www.researchgate.net/publication/343434086/figure/fig1/AS:929201238593537@1598550247348/Dolutegravir-mean-plasma-concentration-versus-time-profiles-by-weight-band-and-dose-30-mg.png)